Details for 2020721083
Up to date per 03.04.2026
Actions
Details for 2020721083
Granted/Registered
European Patent
16.02.2022 A
17.04.2024 B1
12.04.2019
US
201962833529 P
04.10.2019
US
201962911016 P
04.11.2019
US
201962930240 P
C07D 487/04 20060101AFI20201016BHEP
Owner
Blueprint Medicines Corporation45 Sidney Street Cambridge, MA 02139US
Representative
No representatives present
Inventor
KIM, Joseph, L.45 Sidney Street Cambridge, MA 02139US
DINEEN, Thomas, A.45 Sidney Street Cambridge, MA 02139US
GUZI, Timothy45 Sidney Street Cambridge, MA 02139US
Information about Fees